Co-Diagnostics, Inc. - Common Stock (CODX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2017 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CODX on Nasdaq
Shares outstanding
38,539,454
Price per share
$0.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,618,977
Total reported value
$1,933,651
% of total 13F portfolios
0%
Share change
+469,930
Value change
+$165,977
Number of holders
33
Price from insider filings
$0.17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Co-Diagnostics, Inc. - Common Stock (CODX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ayrton Capital LLC 9.7% $1,360,751 3,738,327 Ayrton Capital LLC 30 Sep 2025
Orca Capital AG 3.7% -18% $818,338 +$19,827 2,248,182 +2.5% Orca Capital AG 28 Oct 2025
VANGUARD GROUP INC 3.5% $620,967 1,705,952 The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 33 institutional investors reported holding 5,618,977 shares of Co-Diagnostics, Inc. - Common Stock (CODX). This represents 15% of the company’s total 38,539,454 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Co-Diagnostics, Inc. - Common Stock (CODX) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.4% 1,705,952 -1.6% 0% $586,848
Private Advisory Group LLC 3.1% 1,181,633 0% 0.04% $406,482
RENAISSANCE TECHNOLOGIES LLC 2.3% 867,522 +55% 0% $298,428
BlackRock, Inc. 1.1% 427,440 0% 0% $147,039
GEODE CAPITAL MANAGEMENT, LLC 0.83% 319,990 0% 0% $110,106
HRT FINANCIAL LP 0.39% 149,291 +1022% 0% $51,000
Bank of New York Mellon Corp 0.36% 137,067 0% 0% $47,151
Kestra Advisory Services, LLC 0.35% 134,694 +4.7% 0% $46,335
Virtu Financial LLC 0.33% 126,524 +394% 0% $44,000
UBS Group AG 0.31% 118,244 +9344% 0% $40,676
STATE STREET CORP 0.26% 100,647 0% 0% $34,623
JANE STREET GROUP, LLC 0.16% 62,251 -63% 0% $21,414
NORTHERN TRUST CORP 0.14% 54,977 0% 0% $18,912
GROUP ONE TRADING LLC 0.14% 54,298 +5131% 0% $18,679
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.12% 45,136 -64% 0% $15,527
ENVESTNET ASSET MANAGEMENT INC 0.08% 30,840 +87% 0% $10,609
SMI Advisory Services, LLC 0.07% 28,000 0% 0% $10,750
SIMPLEX TRADING, LLC 0.05% 18,930 +230% 0% $6,000
Regal Investment Advisors LLC 0.04% 16,000 +6.7% 0% $5,504
Ground Swell Capital, LLC 0.03% 11,517 0.01% $3,962
CITADEL ADVISORS LLC 0.03% 10,589 0% $3,643
MORGAN STANLEY 0.02% 5,793 -2.7% 0% $1,993
Global Retirement Partners, LLC 0.01% 3,000 0% 0% $1,032
OSAIC HOLDINGS, INC. 0.01% 1,940 0% 0% $632
Tower Research Capital LLC (TRC) 0% 1,501 0% $516

Institutional Holders of Co-Diagnostics, Inc. - Common Stock (CODX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,181,633 $199,223 -$10,749 $0.17 1
2025 Q3 5,618,977 $1,933,651 +$165,977 $0.34 33
2025 Q2 5,152,077 $1,441,316 -$212,863 $0.28 35
2025 Q1 5,842,772 $1,809,752 -$47,797 $0.31 37
2024 Q4 5,710,586 $4,282,338 +$957,519 $0.75 37
2024 Q3 4,413,670 $5,518,477 -$287,380 $1.25 36
2024 Q2 4,643,146 $5,806,110 +$363,707 $1.25 43
2024 Q1 4,360,457 $4,889,752 -$425,667 $1.12 37
2023 Q4 525 $698 $1.33 1
2023 Q3 4,558,729 $4,832,638 +$119,650 $1.06 44
2023 Q2 4,437,971 $4,927,496 -$1,192,285 $1.11 43
2023 Q1 5,417,264 $8,017,283 -$944,326 $1.48 50
2022 Q4 5,775,899 $14,565,440 -$924,112 $2.52 54
2022 Q3 6,191,057 $19,877,193 -$5,851,633 $3.21 55
2022 Q2 7,236,474 $40,248,700 +$3,007,352 $5.61 65
2022 Q1 6,822,189 $42,157,405 -$2,531,953 $6.18 73
2021 Q4 7,107,855 $63,476,145 -$8,254,727 $8.93 73
2021 Q3 7,939,878 $77,158,550 +$9,820,217 $9.73 76
2021 Q2 7,238,112 $59,813,608 -$18,464,280 $8.25 83
2021 Q1 9,001,309 $85,824,334 +$10,059,077 $9.54 91
2020 Q4 6,126,815 $57,026,268 -$999,770 $9.30 79
2020 Q3 7,587,166 $103,172,527 +$10,811,945 $13.59 75
2020 Q2 6,679,955 $129,181,455 +$88,922,833 $19.35 83
2020 Q1 2,118,914 $16,144,001 +$10,110,150 $7.62 41
2019 Q4 919,987 $823,000 +$43,210 $0.89 8
2019 Q3 867,352 $893,000 +$13,494 $1.03 7
2019 Q2 947,975 $774,000 -$699,469 $0.81 10
2019 Q1 1,807,172 $1,915,000 +$1,674,118 $1.06 8
2018 Q4 223,175 $327,000 -$22,383 $1.46 6
2018 Q3 237,905 $625,000 +$76,673 $2.63 5
2018 Q2 208,609 $810,000 +$238,185 $3.88 5
2018 Q1 155,396 $340,000 -$40,907 $2.20 7
2017 Q4 164,673 $448,000 +$49,759 $2.72 6
2017 Q3 146,972 $919,000 +$919,001 $6.29 4